0       0


New Immunosuppressive Agents in Transplantation: Ale-, Bela-, and More


Sep 9, 2012 8:55am ‐ Sep 9, 2012 9:20am

Description

Attendees will learn:

  • Molecular mechanisms of currently used immunosuppressive drugs used to inhibit T cell activation in transplant patients
  • Use of immune monitoring assays to either predict or detect the presence of acute and/or chronic graft injury in transplant patients
  • Newly developed immunosuppressive reagents that are being incorporated into treatment strategies in the clinic as well as reagents in the pipe line that will potentially be used in transplantation
  • What transplant tolerance is and what it is not
  • Cellular and molecular mechanisms underlying the establishment of transplant tolerance in preclinical models
  • How transplant patients may become tolerant and how the development and/or establishment of tolerance in clinical transplantation are assessed

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content